SCHEMBL7813124

SCHEMBL7813124

O=C1c2ccccc2C(=O)c2sc(-c3ccc(Br)o3)nc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 7/20 0.55
▸ TDO2 P48775 5/20 0.55
▸ ALDH1A1 P00352 4/20 0.39
▸ LMNA P02545 2/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ POLB P06746 4/20 0.39
▸ MAPT P10636 3/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ PKM P14618 2/20 0.39
▸ RECQL P46063 2/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ MCL1 Q07820 1/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ PTK2B Q14289 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ NPC1 O15118 6/20 0.37
▸ RAB9A P51151 6/20 0.37
▸ KMT2A Q03164 5/20 0.37
▸ MEN1 O00255 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7811891 0.83 IDO1 (0.55) IDO1TDO2ALDH1A1POLBMAPT
SCHEMBL7808342 0.83 IDO1 (0.55) IDO1TDO2ALDH1A1MAPTSMN1; SMN2
SCHEMBL7814769 0.83 IDO1 (0.55) IDO1TDO2ALDH1A1MAPTPKM
SCHEMBL7812948 0.81 IDO1 (0.52) IDO1TDO2ALDH1A1LMNAMAPT
SCHEMBL7807731 0.81 IDO1 (0.52) IDO1TDO2ALDH1A1MAPTSMN1; SMN2
SCHEMBL7805785 0.80 IDO1 (0.53) IDO1TDO2ALDH1A1MAPTSMN1; SMN2
SCHEMBL7811413 0.79 IDO1 (0.50) IDO1TDO2POLBNPC1RAB9A
SCHEMBL7816639 0.77 IDO1 (0.57) IDO1TDO2ALDH1A1LMNAPOLB
SCHEMBL7805846 0.77 IDO1 (0.48) IDO1TDO2ALDH1A1POLBMAPT
SCHEMBL7811377 0.76 IDO1 (0.52) IDO1TDO2ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876356-B1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF INNOTHERA SA LAB (FR) 2001-10-31 — — EP claimed
EP-0876356-B1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF INNOTHERA SA LAB (FR) 2001-10-31 — — EP disclosed
US-6262095-B1 TREATMENT OF ILLNESS ASSOCIATED WITH AN ALTERATION IN VENOUS FUNCTION AND/OR INFLAMMATORY EDEMA LABORATOIRE INNOTHERA (FR) 2001-07-17 — — US disclosed
EP-0876356-A1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF LABORATOIRE INNOTHERA Société Anonyme (FR) 1998-11-11 — — EP disclosed
WO-1997021684-A1 USE OF TRICYCLIC 1,4-DIHYDRO-1,4-DIOXO-1H-NAPHTHALENE DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF LABORATOIRE INNOTHERA, SOCIETE ANONYME (FR) 1997-06-19 — — WO disclosed
Send feedback